Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,174 across all filing types
Latest filing 2026-04-02 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
关于2026年第一季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bonds (可转债) of the company 仙乐健康科技股份有限公司 for the first quarter of 2026. It details the status of convertible bonds, including the number of bonds converted, remaining bonds, bond issuance and listing information, and changes in shareholding related to convertible bonds. The document is relatively short (2172 characters) and primarily provides an update on convertible bond conversion and shareholding changes rather than comprehensive financial statements or detailed financial analysis. It does not contain full financial results or management discussion but is a specific update on capital structure related to convertible bonds. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2026-04-02 Chinese
关于2026年第一季度取得发明专利证书和保健食品注册证书、备案凭证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about obtaining new invention patent certificates and health food registration certificates during the first quarter of 2026. It details the number and specifics of patents and certificates obtained, emphasizing their positive impact on the company's intellectual property and market competitiveness. The document is relatively short (1772 characters) and serves as a formal disclosure of these achievements rather than a detailed financial or management report. It does not contain financial statements, earnings data, or management discussion. It is a regulatory announcement informing investors about new patents and certifications, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2026-04-02 Chinese
关于“仙乐转债”回售的第六次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the conditional repurchase (回售) of convertible bonds (仙乐转债) issued by the company 仙乐健康科技股份有限公司. It includes specific dates, prices, procedures, and regulatory references related to the bond repurchase. The document is relatively short (3280 characters) and focuses on a specific financing event related to the company's convertible bonds. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an annual or interim report, nor an earnings release or audit report. The content clearly relates to a capital/financing update about bond repurchase rights and procedures. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-03-31 Chinese
关于“仙乐转债”回售的第五次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the conditional repurchase (回售) of convertible bonds ('仙乐转债') issued by the company. It includes specific dates, prices, procedures, and regulatory references related to the bond repurchase event. The content focuses on the terms and conditions of the bond repurchase, the timeline for bondholders to exercise their repurchase rights, and the payment schedule. There is no financial statement, earnings data, or management discussion of financial results. The document is not a report but an announcement about a capital market event related to bond repurchase. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as bond repurchases or convertible bond redemptions.
2026-03-30 Chinese
关于“仙乐转债”回售的第四次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the conditional repurchase (回售) of convertible bonds (仙乐转债) issued by the company 仙乐健康科技股份有限公司. It includes specific dates, prices, procedures, and regulatory references related to the bond repurchase. The content is focused on informing investors about the bond repurchase event, its terms, and the process, rather than presenting financial statements or results. The document length is 3280 characters, which is relatively short and typical for an announcement rather than a full report. It does not contain financial statements or comprehensive financial analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or officer attestation. The document fits best into the category of Capital/Financing Update (CAP), as it provides an update on a financing activity (bond repurchase).
2026-03-27 Chinese
关于2026年员工持股计划实施进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of the company's 2026 employee stock ownership plan. It references prior board and shareholder meetings where the plan was approved and states that the plan has not yet purchased company stock as of a certain date. The document is short (719 characters) and serves as an update on the implementation status of a capital-related plan (employee stock ownership). It does not contain financial statements or detailed financial data, nor is it a full report or presentation. It is an update on a capital/financing activity related to employee stock ownership plans, which fits best under Capital/Financing Update (CAP).
2026-03-27 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.